Borja Enrique Sanz-Cuesta
Autonomous University of Madrid
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Borja Enrique Sanz-Cuesta.
Neurology | 2013
Patricia Martínez-Sánchez; Blanca Fuentes; Marta Martínez-Martínez; Gerardo Ruiz-Ares; Jorge Fernández-Travieso; Borja Enrique Sanz-Cuesta; Lorena Cuéllar-Gamboa; Elena Díaz-Domínguez; Exuperio Díez-Tejedor
Objective: To examine the effects of pretreatment with statins at high doses (40 mg of rosuvastatin or 80 mg of any other statin) and low to moderate doses (<40 mg of rosuvastatin or <80 mg of any other statin) on ischemic stroke (IS) severity in clinical practice. Methods: Observational study of IS admissions to our stroke unit over a 3-year period (2008–2010). Mild stroke severity was defined as NIH Stroke Scale score ≤5 on admission. Multivariable regression models and matched propensity score analyses were used to quantify the association of statin pretreatment at high and low to moderate doses with mild stroke severity. Results: Of the 969 IS patients, 23% were taking low to moderate doses and 4.1% were taking high doses of statins prior to the stroke. Statins were associated with lower NIHSS scores on admission (median [interquartile range] 4 [9] for nonstatin patients, 4 [9] for low to moderate doses of statins, and 2 [4] for high doses of statins; p = 0.010). After multivariable adjustment, pretreatment with statins was associated with a higher probability of mild stroke severity in the unmatched analysis (odds ratio [OR] = 1.637, 95% confidence interval [CI] 1.156–2.319 for the low to moderate doses and OR = 3.297, 95% CI 1.480–7.345 for the high doses of statins) as well as in the propensity score matched analysis (OR = 2.023, 95% CI 1.248–3.281 for the low to moderate doses and OR = 3.502, 95% CI 1.477–8.300 for the high doses of statins). Conclusion: Pretreatment with statins is associated with lower stroke severity, at high as well as at low to moderate doses.
Internal Medicine Journal | 2014
Juan José Arévalo-Manso; Patricia Martínez-Sánchez; B. Juarez‐Martin; Blanca Fuentes; Gerardo Ruiz-Ares; Borja Enrique Sanz-Cuesta; P. Parrilla‐Novo; Exuperio Díez-Tejedor
We aimed to evaluate the relationship between the length of time acute stroke patients underwent enteral tube feeding (ETF) and episodes of diarrhoea, and to investigate the temporal cut‐off point at which diarrhoea risk increases.
Journal of NeuroInterventional Surgery | 2017
María Alonso de Leciñana; Patricia Martínez-Sánchez; A. García-Pastor; Michal M. Kawiorski; Patricia Calleja; Borja Enrique Sanz-Cuesta; Fernando Díaz-Otero; R. Frutos; Fernando Sierra-Hidalgo; Gerardo Ruiz-Ares; Eduardo Fandiño; Exuperio Díez-Tejedor; Antonio Gil-Núñez; Blanca Fuentes
Background and purpose The present study was conducted with the objective of evaluating the safety of primary mechanical thrombectomy (MT) in patients with large vessel occlusion (LVO) stroke and comorbidities that preclude treatment with IV thrombolysis (IVT), compared with patients who received standard IVT treatment followed by MT. Secondary objectives were to analyse the recanalization rate and outcomes. Methods A prospective observational multicenter study (FUN-TPA) that recruited patients treated within 4.5 hours of symptom onset was performed. Treatments were IVT followed by MT if occlusion persisted, or primary MT when IVT was contraindicated. Outcome measures were procedural complications, symptomatic intracranial hemorrhage (SICH), recanalization rate, National Institutes of Health Stroke Scale (NIHSS) score at 7 days, modified Rankin Scale (mRS) score and mortality at 90 days. Results Of 131 patients, 21 (16%) had medical contraindications for IVT and were treated primarily with MT whereas 110 (84%) underwent IVT, followed by MT in 53 cases (40%). The recanalization rate and procedural complications were similar in the two groups. There were no SICHs after primary MT vs 3 (6%) after IVT+MT. Nine patients (43%) in the primary MT group achieved independence (mRS 0–2) compared with 36 (68%) in the IVT+MT group (p=0.046). Mortality rates in the two groups were 14% (n=3) vs 4% (n=2) (p=0.13). Adjusted ORs for independence in patients receiving standard IVT+MT vs MT in patients with medical contraindications for IVT were 2.8 (95% CI 0.99 to 7.98) and 0.24 (95% CI 0.04 to 1.52) for mortality. Conclusions MT is safe in patients with potential comorbidity-derived risks that preclude IVT. MT should be offered, aiming for prompt recanalization, to patients with LVO stroke unsuitable for IVT. Trial registration number NCT02164357; Results.
Headache | 2017
Jorge Rodríguez-Pardo; Manuel Lara‐Lara; Borja Enrique Sanz-Cuesta; Blanca Fuentes; Exuperio Díez-Tejedor
To perform a literature review of the epidemiology, clinical presentation, diagnostic evaluation, and clinical course of occipital condyle syndrome, including a new case report.
Journal of Diabetes | 2015
Andrés Cruz-Herranz; Blanca Fuentes; Patricia Martínez-Sánchez; Gerardo Ruiz-Ares; Manuel Lara‐Lara; Borja Enrique Sanz-Cuesta; Exuperio Díez-Tejedor
Patients with diabetes mellitus (DM) are more likely to develop in‐hospital complications (IHCs) than patients without DM. In addition, they have poorer outcomes after an ischemic stroke (IS). Our goal was to evaluate whether the increase in risk for the development of IHCs in patients with IS is due to DM per se, to poor metabolic control of the DM or to glucose levels on admission.
International Journal of Clinical Practice | 2015
Juan José Arévalo-Manso; Patricia Martínez-Sánchez; B. Juarez‐Martin; Blanca Fuentes; Gerardo Ruiz-Ares; Borja Enrique Sanz-Cuesta; P. Parrilla‐Novo; Exuperio Díez-Tejedor
To meet the current recommendations for enteral tube feeding (ETF), we updated our previous practice in 2011 and began to use a 24‐h delivery set hang time (DSHT). We evaluated the impact of this update on the risk of diarrhoea and in diarrhoea‐free survival.
European Journal of Cardiovascular Nursing | 2016
Juan José Arévalo-Manso; Patricia Martínez-Sánchez; Blanca Fuentes; Gerardo Ruiz-Ares; Borja Enrique Sanz-Cuesta; Daniel Prefasi; Belén Juarez-Martin; Azahara Navarro-Parias; Pilar Parrilla-Novo; Exuperio Díez-Tejedor
Introduction: It is unknown whether monitors that include atrial fibrillation recognition software (AF-RS) increase the rate of early atrial fibrillation (AF) detection in acute stroke. We aimed to evaluate the AF detection rate of an AF-RS monitor and compare it with standard monitoring. Methods: This was a retrospective, single-centre observational study conducted on consecutive patients with acute transient ischaemic attack or brain infarction attended in a stroke unit (SU) with six beds. Five beds had a standard monitor with a three-lead electrocardiogram (ECG)-tracing monitor that did not automatically detect AF, and one bed had a 12-lead ECG monitor with integrated AF-RS. All patients were monitored for at least 24 h and underwent a daily ECG during their stay in the SU. In case of unknown stroke aetiology, the patients underwent 24 h Holter monitoring. Results: A total of 76 patients were included: 59 patients in the standard monitor group and 17 patients in the AF-RS monitor group. The mean age was 72.11 (±13.09) years, and 59.2% were men. A total of 20 new cases of AF were identified. The AF-RS monitor showed a higher rate of AF detection than the standard devices (57.1% vs 7.7%, p=0.031). The AF-RS monitor showed sensitivity, specificity, positive predictive value, and negative predictive values of 57.1%, 100%, 100% and 76.9%, respectively. For the standard monitors, these values were 7.7%, 100%, 100% and 79.3%, respectively. Conclusion: The monitor with AF-RS demonstrated a higher detection rate for AF than standard ECG monitoring in acute stroke patients in a SU.
Neuroradiology | 2016
Michal M. Kawiorski; Patricia Martínez-Sánchez; A. García-Pastor; Patricia Calleja; Blanca Fuentes; Borja Enrique Sanz-Cuesta; Daniel Lourido; Begoña Marín; Fernando Díaz-Otero; Agustina Vicente; Fernando Sierra-Hidalgo; Gerardo Ruiz-Ares; Exuperio Díez-Tejedor; Eduardo Fandiño; María Alonso de Leciñana
Journal of Neurology | 2014
Patricia Martínez-Sánchez; Ambrosio Miralles; Rosa Sanz de Barros; Daniel Prefasi; Borja Enrique Sanz-Cuesta; Blanca Fuentes; Gerardo Ruiz-Ares; Marta Martínez-Martínez; Elena Miñano; Juan José Arévalo-Manso; Elisa Correas-Callero; Andrés Cruz-Herranz; Exuperio Díez-Tejedor
Journal of Thrombosis and Thrombolysis | 2014
Daniel Prefasi; Blanca Fuentes; Patricia Martínez-Sánchez; Ana Rodríguez-Sanz; Gerardo Ruiz-Ares; Borja Enrique Sanz-Cuesta; Manuel Lara; Exuperio Díez-Tejedor